Summary
Although androgens exert major effects on bone remodeling, the mechanisms by which they exert their effects remain unclear. Recently, it has become apparent that receptors for sex steroids may be present in osteoblastic cells. We have examined several cell lines with osteoblastic phenotypes to determine if specific, high affinity androgen receptors are present. Two cell lines of human origin (Saos-2 and U2-OS) and one of rat origin (UMR-106.01) were studied. Androgen binding sites were present in all cell lines. Binding affinities were high (KD=1.6−2.5×10−10 M), and similar to those in classical androgen target tissues (prostate, kidney). Concentrations were greater in the human cell lines (1277 and 1605 sites/cell) than in the rodent line (74 sites/cell). In the human cell lines androgen binding was also specific and typical of androgen receptors in other tissues. Specific estrogen binding was not present in the UMR-106.01 cells, and no estrogen receptors were detectable in the human cell lines using an enzyme-linked receptor immunoassay. Specific binding for progesterone was also absent in the UMR-106.01 cells, but progesterone receptors were detected immunologically in the Saos-2 (119 sites/cell) and U2-OS (118 sites/cell) lines. These findings indicate the presence of androgen receptors that are of similar character to those in classical androgen target tissues, and suggest that the study of these cell lines may be useful in the study of the regulation of androgen effects in osteoblasts.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Tabuchi C, Simmons DJ, Fausto A, Rusell JE, Binderman I, Avioli LV (1986) Bone deficit in ovariectomized rats. J Clin Invest 78:637
Stock JL, Coderre JA, Mallette LE (1985) Effects of a short course of estrogen on mineral metabolism in postmenopausal women. J Clin Endocrinol Metab 61:595
Gallagher JC, Riggs BL, DeLuca JF (1980) Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab 51:1359
Ettinger B, Genant HK, Cann CE (1985) Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 102:319
Cheema C, Grant BF, Marcus R (1989) Effects of estrogen on circulating “free” and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in postmenopausal women. J Clin Invest 83:537
Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Korc M, Greene GL, O'Malley BW, Haussler MR (1988) Estrogen binding, receptor mRNA and biologic response in osteoblast-like osteosarcoma cells. Science 241:81
Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84
Gray TK, Flynn TC, Gray KM, Nabell LM (1987) 17β-Estradiol acts directly on the clonal osteoblastic cell line UMR106. Proc Natl Acad Sci 84:6267
Ernst M, Schmid CH, Froesch ER (1988) Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci 85:2307
Fukayama S, Tashjian AH (1989) Direct modulation by estradiol of the response of human bone cells (Saos-2) to human parathyroid hormone (PTH) and PTH-related protein. Endocrinology 124:397
Bankson DD, Rifai N, Williams ME, Silverman LM, Gray TK (1989) Biochemical effects of 17β-estradiol on UMR106 cells. Bone Miner 6:55
Colvard DS, Eriksen EF, Keeting PE, Wilson EM, Lubahn DB, French FS, Riggs BL, Spelsberg TC (1989) Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci 86:854
Kasperk CH, Wergedal JE, Farley JR, Linkhart TA, Turner RT, Baylink DJ (1989) Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 124:1576
Vaishnav R, Beresford JN, Gallagher JA, Russell RGG (1988) Effects of the anabolic steroid stanozolol on cells derived from human bone. Clin Sci 74:455
Fukayama S, Tashjian AH (1989) Direct modulation by androgens of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein. Endocrinology 125:1789
Seeman E, Melton LJ III, O'Fallon WM, Riggs BL (1983) Risk factors for spinal osteoporosis in men. Am J Med 75:977
Greenspan SL, Oppenheim DS, Klinbanski A (1989) Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 110:526
Finkelstein JS, Klinbanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF (1987) Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Méd 106:354
Finkelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal DI, Segre GV, Crowley WF (1989) Increases in bone density during treatment of men with idiopathic hypogonadrotropic hypogonadism. J Clin Endocrinol Metab 69:776
Johansen JS, Hassager C, Podenphant J, Riis BJ, Hartwell D, Thomsen K, Christiansen C (1989) Treatment of postmenopausal osteoporosis: Is the anabolic steroid nandrolone decanoate a candidate? Bone Miner 6:77
Nordin BEC, Robertson A, Seamark RF, Bridges A, Philcox JC, Need AG, Horowitz M, Morris HA, Deam S (1985) The relation between calcium absorption, serum dehydroepiandrosterone, and vertebral mineral density in postmenopausal women. J Clin Endocrinol Metab 60:651
Need AG, Horowitz M, Walker CJ, Chatterton BE, Chapman IC, Nordin BEC (1989) Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis. Bone 10:3
Burton K (1956) A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660
Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM (1988) Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240:327
Chang C, Kokontis J, Liao S (1988) Molecular closing of human and rat complementary DNA encoding androgen receptors. Science 240:324
Fang S, Liao S (1971) Androgen receptors. J Biol Chem 246:16
Liao S, Liang T, Fang S, Castaneda E, Shao TS (1973) Steroid structure and androgenic activity. Specificities involved in the receptor binding and nuclear retention of various androgens. J Biol Chem 248:6154
Berger FG, Watson G (1989) Androgen-regulated gene expression. Annu Rev Physiol 51:51
Ellison KE, Ingelfinger JR, Pivor M, Dzau VJ (1989) Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Invest 83:1941
Colston KW, King RJB, Hayward J, Fraser DI, Horton MA, Stevenson JC, Arnett TR (1989) Estrogen receptors and human bone cells: immunocytochemical studies. J Bone Miner Res 4:625
Lindsay R, Hart DM, Purdie D (1978) Comparative effects of estrogen and a progestogen on bone loss in postmenopausal women. Clin Sci Mol Med 54:193
Snow GR, Anderson C (1985) The effects of continuous progestogen treatment on cortical bone remodeling activity in beagles. Calcif Tissue Int 37:282
Mandel FP, Davidson BJ, Erlik Y, Judd HL, Meldrum DR (1982) Effects of progestins on bone metabolism in postmenopausal women. J Reprod Med 27:511
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Orwoll, E.S., Stribrska, L., Ramsey, E.E. et al. Androgen receptors in osteoblast-like cell lines. Calcif Tissue Int 49, 183–187 (1991). https://doi.org/10.1007/BF02556115
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02556115